Roskilde university | Denmark
Author Profile
Scopus
Orcid
🔬Biography: Prof. Dr. Havard Jenssen 🧬✨
Expert in Antimicrobial Peptide Chemistry and Drug Development
Prof. Dr. Håvard Jenssen is a distinguished scientist and educator specializing in antimicrobial peptide chemistry, virology, and statistical analysis. With a career spanning multiple countries and institutions, he has contributed significantly to the development of innovative antimicrobial therapies and biofilm prevention strategies.
📚Education
- B.Sc. in Biochemistry, Oslo College of Engineering (1994–1997)
- C.E. in Biotechnology, University of Tromsø (1997–1999)
- Dr.Sc. in Peptide Chemistry, Virology, and Statistical Analysis, University of Tromsø (2003–2004)
- Doctoral degree awarded on February 7, 2005
🎓Continuing Education✨
- Qualified as Associate Professor through RUC’s Assistant Professorship Program (2009)
- Specialized in Course Pedagogy, ICT and Teaching, and Project Supervision (2010)
- Training in Teaching in English as an International Language (2011)
- Completed Project Leader – Organization and Leadership Training (2014)
🏛️Professional Appointments
- Associate Professor (Adjunct), University of Oslo (2024–Present)
- Professor, Dept. of Science, Systems & Models, Roskilde University, Denmark (2017–Present)
- Associate Professor, Roskilde University, Denmark (2009–2017)
- Research Associate, CMDR, University of British Columbia, Canada (2008–2009)
- Postdoctoral Fellow, CMDR, University of British Columbia, Canada (2005–2007)
- Research Associate, Dept. of Microbiology, University Hospital of North Norway (2000–2002)
🌍Research Contributions🧪
Prof. Jenssen has made groundbreaking advances in the field of antimicrobial drug development, notably through projects supported by significant funding, such as:
- A collaboration with Alpharma and University of Tromsø with an annual budget of 15 million NOK.
- Research efforts that contributed to total funding exceeding $25 million USD.
💡Patents🧬
- PTC/US14/52993 – UBC invention disclosure: “Anti-biofilm peptides”.
- WO 2010/139048 A1 – Human Milk Peptides (Friel K.J. et al., 12/09/2010).
🌟Impact and Leadership
Prof. Jenssen is highly regarded for his expertise in antimicrobial peptides, their applications in combating drug-resistant infections, and his dedication to teaching and mentoring the next generation of scientists.
✨Conclusion:
-
In conclusion, Prof. Dr. Håvard Jenssen is a prominent figure in the fields of antimicrobial peptide chemistry and drug development. His extensive education, research experience, and leadership in both academia and industry have led to significant contributions to the development of new antimicrobial therapies. Prof. Jenssen’s innovative work, including patented anti-biofilm peptides and human milk peptides, underscores his commitment to advancing scientific knowledge and tackling global health challenges. His dedication to teaching and mentoring also ensures that his expertise will continue to shape the future of science and technology in antimicrobial research.